Share Your Experiences with Healthcare Issues – May 2015

Share Your Experiences with Healthcare Issues YourCareMoments provides valuable opinions and experiences to pharmaceutical and health insurance companies. The topics are related to the affordability of and access to medications. YourCareMoments relays consumer habits, decisions and healthcare experiences through short online surveys that are sent to people who register with them. You must be at…

The Ryan Report – May 2019

The Ryan Report Home Oxygen Guru – The HO2G Pen  2019 Portable Oxygen Concentrator Guide Howdy ho! Welcome to the 2019 version of our annual Portable Oxygen Concentrator (POC) Guide. Another year has gone by and still we don’t have any significant developments in terms of smaller continuous flow-capable POC devices. Manufacturers seem content for…

Editor’s Note – May 2019

Editor’s Note Welcome to our annual review of Portable Oxygen Concentrators (POCs)! While we wait and wait for a smaller machine that will give us continuous flow higher than a setting of 3, Ryan has updated his data on the POCs currently on the market. Through an independent testing and consulting company, Valley Inspired Products, Ryan…

Oxygen Needs in Pulmonary Fibrosis – May 2019

Oxygen Needs in Pulmonary Fibrosis People who have pulmonary fibrosis often need higher oxygen flow rates to maintain their oxygen saturations. Unlike obstructive lung disease, this is because the lung muscle itself is usually thick (fibrotic) and is comparable to being scarred. You need extra flow to get the oxygen across your lung to be…

Calling Dr. Bauer – March 2019

Calling Dr. Bauer In all the exam rooms at our clinic, we have a large poster on the wall that displays the most recent inhalers available on the market. This is helpful for me to share this with each person so I can confirm exactly which inhalers he/she is using. It seems every six months…

Respiratory News – March 2019

Respiratory News The FDA has accepted a supplemen- tal New Drug Application for Xofluza (baloxavir marboxil) as a single-dose, oral treatment for people at high risk of complications from the flu, according to Genentech. A decision on approval of the new medication should come by November of this year. Studies found that Xofluza sig- nificantly…